Harbin Pharmaceutical Group Co., Ltd.
SHH: 600664.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chuanyou Lu
- Employees
- 10,180
- Headquarters
- Harbin, China
- IPO year
- 1993
- Market cap
- CN¥9.5B
- Website
- https://www.hayao.com
Loading 600664…
Loading profile data…Frequently asked questions about 600664
What does Harbin Pharmaceutical Group Co., Ltd. (600664.SS) do?
Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company operates through seven segments: Antibiotics, Small-Molecular Drug Preparations, OTC and Healthcare Products, Modern Chinese Medicines, Biopharmaceuticals, Animal Vaccines, and Medicine C...
Where does 600664.SS trade?
Harbin Pharmaceutical Group Co., Ltd. (600664.SS) trades on the Shanghai Stock Exchange.
What sector is 600664.SS in?
Harbin Pharmaceutical Group Co., Ltd. (600664.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Harbin Pharmaceutical Group Co., Ltd.?
Chuanyou Lu is the chief executive officer of Harbin Pharmaceutical Group Co., Ltd. (600664.SS).
Where is Harbin Pharmaceutical Group Co., Ltd. headquartered?
Harbin Pharmaceutical Group Co., Ltd. is headquartered in China.
Does 600664.SS pay a dividend?
Harbin Pharmaceutical Group Co., Ltd. (600664.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 600664.SS go public?
Harbin Pharmaceutical Group Co., Ltd. (600664.SS) completed its initial public offering in 1993.